44 of the patients in the AAA approach of Hansen et al. experienced arterial hypertension [33], but this refers only to the test phase. During the pinning, craniotomy and tumour resection there were only 5 patients with 10?0 increase in blood pressure. Additional analyses. The analysis of the composite outcome, including AC failure, intraoperative seizure and mortality was based on forty-one studies (S1 Fig) [10,17?6,28?0,32,34?41,43,46?2]. Of note, intraoperative seizure events, which concurrently led to an AC failure, were counted only once for this composite outcome. The total proportion was estimated to be 8 [95 CI: 6?1], with 8 [95 CI: 6?2] in the MAC group and 8 [95 CI: 5?2] in the SAS group. Logistic meta-regression did not show a difference of the event rate depending on the technique (MAC/ SAS). The OR was 0.9 [95 CI: 0.47?.76] and the residual heterogeneity I2 = 80 .PLOS ONE | DOI:10.1371/journal.pone.0156448 May 26,32 /Anaesthesia Management for Awake CraniotomyFig 4. Forrest plot of intraoperative seizures. The summary value is an overall estimate from a random-effect model. The vertical dotted line shows an overall estimate of Mitochondrial division inhibitor 1 chemical information outcome proportion (based on the meta-analysis) disregarding grouping by technique. Of note, Souter et al. [60] have used both anaesthesia techniques. doi:10.1371/journal.pone.0156448.gSensitivity analysis, by including only prospectively conducted trials, was performed to look at the robustness of our findings in the main summary measure U0126-EtOH chemical information analyses of the four outcomes (AC failure, conversion to GA, intraoperative seizure and new neurological dysfunction) andPLOS ONE | DOI:10.1371/journal.pone.0156448 May 26,33 /Anaesthesia Management for Awake CraniotomyFig 5. Forrest plot of new neurological dysfunction. The summary value is an overall estimate from a random-effect model. The vertical dotted line shows an overall estimate of outcome proportion (based on the meta-analysis) disregarding grouping by technique. Neurol. dysf., neurological dysfunction. doi:10.1371/journal.pone.0156448.gthe additional analysis of the composite outcome. Sensitivity analysis referred to eighteen trials [10,17,18,21,22,25,26,28,30,32,35,36,38,47,52,55,56,61], after exclusion of one duplicate study [27]. Of note, it was not possible to predict an estimate for the outcome new neurological dysfunction in the SAS group, because only one prospective SAS study provided data for this outcome [38]. The proportions of outcomes were slightly lower in prospective studies compared to results from the main analysis, which is shown in S2 Fig. The logistic meta-regression models using the independent variables anaesthesia technique (MAC/ SAS) and prospective studies (yes/ no) showed only very small and statistically not significant differences.PLOS ONE | DOI:10.1371/journal.pone.0156448 May 26,34 /Anaesthesia Management for Awake CraniotomyDiscussionOur systematic review has pointed out forty-seven studies addressing three main topics: SAS-, MAC- and AAA-technique of anaesthesia management for AC since 2007. We identified only two small RCTs [32,56] and one pseudo-RCT [36]. These were as well as the remaining observational studies of moderate to low methodological quality. In summary all three anaesthetic approaches were feasible and safe. But our results have to be seen within their limits. Nine of the identified forty-seven studies reported partially duplicate patient data, first the studies of Ouyang et al. [45,46], second the s.44 of the patients in the AAA approach of Hansen et al. experienced arterial hypertension [33], but this refers only to the test phase. During the pinning, craniotomy and tumour resection there were only 5 patients with 10?0 increase in blood pressure. Additional analyses. The analysis of the composite outcome, including AC failure, intraoperative seizure and mortality was based on forty-one studies (S1 Fig) [10,17?6,28?0,32,34?41,43,46?2]. Of note, intraoperative seizure events, which concurrently led to an AC failure, were counted only once for this composite outcome. The total proportion was estimated to be 8 [95 CI: 6?1], with 8 [95 CI: 6?2] in the MAC group and 8 [95 CI: 5?2] in the SAS group. Logistic meta-regression did not show a difference of the event rate depending on the technique (MAC/ SAS). The OR was 0.9 [95 CI: 0.47?.76] and the residual heterogeneity I2 = 80 .PLOS ONE | DOI:10.1371/journal.pone.0156448 May 26,32 /Anaesthesia Management for Awake CraniotomyFig 4. Forrest plot of intraoperative seizures. The summary value is an overall estimate from a random-effect model. The vertical dotted line shows an overall estimate of outcome proportion (based on the meta-analysis) disregarding grouping by technique. Of note, Souter et al. [60] have used both anaesthesia techniques. doi:10.1371/journal.pone.0156448.gSensitivity analysis, by including only prospectively conducted trials, was performed to look at the robustness of our findings in the main summary measure analyses of the four outcomes (AC failure, conversion to GA, intraoperative seizure and new neurological dysfunction) andPLOS ONE | DOI:10.1371/journal.pone.0156448 May 26,33 /Anaesthesia Management for Awake CraniotomyFig 5. Forrest plot of new neurological dysfunction. The summary value is an overall estimate from a random-effect model. The vertical dotted line shows an overall estimate of outcome proportion (based on the meta-analysis) disregarding grouping by technique. Neurol. dysf., neurological dysfunction. doi:10.1371/journal.pone.0156448.gthe additional analysis of the composite outcome. Sensitivity analysis referred to eighteen trials [10,17,18,21,22,25,26,28,30,32,35,36,38,47,52,55,56,61], after exclusion of one duplicate study [27]. Of note, it was not possible to predict an estimate for the outcome new neurological dysfunction in the SAS group, because only one prospective SAS study provided data for this outcome [38]. The proportions of outcomes were slightly lower in prospective studies compared to results from the main analysis, which is shown in S2 Fig. The logistic meta-regression models using the independent variables anaesthesia technique (MAC/ SAS) and prospective studies (yes/ no) showed only very small and statistically not significant differences.PLOS ONE | DOI:10.1371/journal.pone.0156448 May 26,34 /Anaesthesia Management for Awake CraniotomyDiscussionOur systematic review has pointed out forty-seven studies addressing three main topics: SAS-, MAC- and AAA-technique of anaesthesia management for AC since 2007. We identified only two small RCTs [32,56] and one pseudo-RCT [36]. These were as well as the remaining observational studies of moderate to low methodological quality. In summary all three anaesthetic approaches were feasible and safe. But our results have to be seen within their limits. Nine of the identified forty-seven studies reported partially duplicate patient data, first the studies of Ouyang et al. [45,46], second the s.
Related Posts
N, and contribute to angiogenesis and granulation tissue formation. As such, EGFs are important for
N, and contribute to angiogenesis and granulation tissue formation. As such, EGFs are important for normal injury and repair processes. In chronic wounds, inadequate levels of EGF and EGFR happen to be observed.74 For the reason that of this, exogenous EGF has been applied in clinical trials for treatment of nonhealing wounds. Unfortunately, EGF did […]
Nal.pone.0052197.gSpecificity of Vascular Reprogramming via ProxSmooth muscle cell conditioned
Nal.pone.0052197.gSpecificity of Vascular Reprogramming via ProxSmooth muscle cell conditioned media does not downregulate ectopic Prox1 in arterial endothelial cellsWith the driver being able to express within the dorsal aorta it is curious that there appears to be no expression of Prox1, suggesting 1326631 that a mechanism may exist that restricts Prox1 expression from this ASP015K […]
Ina (HTCCNC) was established. The HTCCNC, comprises 120 centers throughout the country
Ina (HTCCNC) was established. The HTCCNC, comprises 120 centers throughout the nation, playing a vital role for hemophilia care provision [5, 6]. Affordability and accessibility for hemophilia care have also been enhanced remarkably by the expansion of universal medical insurance coverage coverage, which offers partial economic support for inpatient and outpatient treatment, drugs and diagnostic […]